DAC - Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Dac ID Contact Person Email Access Information
EGAC00001001461 Ian Majewski majewski [at] wehi [dot] edu [dot] au No additional information is available

This DAC controls 1 dataset:

Dataset ID Description Technology Samples
EGAD00001005949 This study assessed molecular determinants of response in a cohort of patients with AML that were treated with venetoclax in combination with either DNA methyltransferase inhibitors or low dose cytarabine. RNA sequencing was performed on 31 patients from three different response classes [10 Group A - Durable remission (n=10), Group B - Relapsed (n=10) and Group C - Refractory (n=11)]. Library preparation and sequencing was performed at the Australian Genome Research Facility, using the Truseq Stranded mRNA library kit. Technical and batch replicate samples are included. Gene count data are provided with the original publication. The use of the sequencing data is subject to a data transfer agreement and is restricted to ethically approved research into blood cell malignancies and cannot be used to assess germline variants. Illumina HiSeq 2500 39